• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未切除的小淋巴结评估可预测 pT3N0M0 胸段食管鳞癌患者的预后。

Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma.

机构信息

Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation Oncology Key Laboratory of Sichuan Province, No.55,Section 4,South Renmin Road, Chengdu, 610042, China.

Department of Medical Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

出版信息

World J Surg Oncol. 2021 Oct 18;19(1):303. doi: 10.1186/s12957-021-02412-1.

DOI:10.1186/s12957-021-02412-1
PMID:34657600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8522218/
Abstract

BACKGROUND

The role of unresected small lymph nodes (LNs) which may contain metastases for thoracic esophageal squamous cell carcinoma (TESCC) has not been addressed. The aim of the study was to investigate the role of unresected small LNs assessment using computed tomography (CT) in prognostic estimates of pT3N0M0 TESCC patients.

METHODS

Between January 2009 and December 2017, 294 patients who underwent esophagectomy with R0 resection at Sichuan Cancer Hospital were retrospectively examined, and the last follow-up time was July 2018. Patients were classified into CT-suspect and CT-negative groups according to the shortest diameter and the shape (axial ratio) of the unresected small LNs on preoperative CT. The Kaplan-Meier method was used to compare survival differences in prognostic factors. Univariate and multivariate analyses were performed to identify prognostic factors for survival and recurrence.

RESULTS

Eighty-four patients (28.6%) were classified as CT-suspect group according to the diagnostic criteria; survival analysis suggested that CT-suspect group of patients had a relatively poorer prognosis (P<0.05). Cox regression analysis indicated that unresected small LNs status, tumor grade, and postoperative adjuvant therapy were independent prognostic factors for patients with pT3N0M0 TESCC (P<0.05). Further analysis shown the rates of total recurrence (TR) and locoregional recurrence (LR) in the CT-suspect group were significantly higher than that in the CT-negative group (TR, P<0.001; LR, P<0.001). Among the LRs, the rate of supraclavicular lymph node recurrence in the CT-suspect group was significantly higher than that in the CT-negative group (P<0.001).

CONCLUSIONS

Unresected small lymph node assessment is critically important and predict prognosis for pT3N0M0 TESCC patients.

摘要

背景

未切除的小淋巴结(LNs)可能包含胸段食管鳞癌(TESCC)的转移,但尚未确定其作用。本研究旨在探讨使用计算机断层扫描(CT)评估未切除的小 LNs 在 pT3N0M0 TESCC 患者预后估计中的作用。

方法

回顾性分析 2009 年 1 月至 2017 年 12 月在四川省肿瘤医院接受 R0 切除食管切除术的 294 例患者的资料,末次随访时间为 2018 年 7 月。根据术前 CT 上未切除的小 LNs 的最短直径和形状(轴向比),将患者分为 CT 可疑组和 CT 阴性组。采用 Kaplan-Meier 法比较预后因素的生存差异。进行单因素和多因素分析以确定生存和复发的预后因素。

结果

根据诊断标准,84 例患者(28.6%)被归类为 CT 可疑组;生存分析表明 CT 可疑组患者的预后相对较差(P<0.05)。Cox 回归分析表明,未切除的小 LNs 状态、肿瘤分级和术后辅助治疗是 pT3N0M0 TESCC 患者的独立预后因素(P<0.05)。进一步分析表明,CT 可疑组的总复发(TR)和局部区域复发(LR)率明显高于 CT 阴性组(TR,P<0.001;LR,P<0.001)。在 LRs 中,CT 可疑组锁骨上淋巴结复发率明显高于 CT 阴性组(P<0.001)。

结论

未切除的小淋巴结评估对于 pT3N0M0 TESCC 患者非常重要,可以预测预后。

相似文献

1
Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma.未切除的小淋巴结评估可预测 pT3N0M0 胸段食管鳞癌患者的预后。
World J Surg Oncol. 2021 Oct 18;19(1):303. doi: 10.1186/s12957-021-02412-1.
2
[Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].[两野淋巴结清扫食管切除术治疗胸段pT3N0M0期食管鳞状细胞癌患者的复发模式]
Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):48-54. doi: 10.3760/cma.j.issn.0253-3766.2016.01.010.
3
Analysis of the causes of failure after radical surgery in patients with TNM thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy.分析 TNM 胸段食管鳞癌根治术后失败的原因及术后放疗的考虑。
World J Surg Oncol. 2017 Oct 25;15(1):192. doi: 10.1186/s12957-017-1259-4.
4
[Prognostic analysis of cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma].[胸段食管鳞状细胞癌患者颈部淋巴结转移的预后分析]
Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):612-6.
5
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.在根治性食管切除术和三野淋巴结清扫术后,颈淋巴结转移在胸段食管鳞状细胞癌中被归类为区域淋巴结分期。
BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.
6
Risk factors for tumor recurrence in patients with pTNM thoracic esophageal squamous cell carcinoma after esophagectomy.胸段食管鳞癌患者术后肿瘤复发的危险因素分析
J Int Med Res. 2020 Dec;48(12):300060520977403. doi: 10.1177/0300060520977403.
7
Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.新辅助化疗及手术治疗可切除胸段食管鳞状细胞癌后,(18)F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)阳性淋巴结的预后意义
Ann Surg Oncol. 2015 Aug;22(8):2599-607. doi: 10.1245/s10434-014-4299-9. Epub 2014 Dec 19.
8
The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描阳性淋巴结对可切除性胸段食管鳞癌术后复发和生存的影响。
Ann Surg Oncol. 2012 Feb;19(2):652-60. doi: 10.1245/s10434-011-1928-4. Epub 2011 Jul 19.
9
[Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].[Ⅲ期胸段食管鳞状细胞癌患者根治性切除术后的复发模式]
Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):48-55. doi: 10.3760/cma.j.issn.0253-3766.2017.01.010.
10
Impact of the number of resected lymph nodes on postoperative survival of patients with node-negative oesophageal squamous cell carcinoma.淋巴结清扫数目对淋巴结阴性食管鳞癌患者术后生存的影响。
Eur J Cardiothorac Surg. 2013 Oct;44(4):631-6. doi: 10.1093/ejcts/ezt097. Epub 2013 Mar 10.

引用本文的文献

1
Theranostic Nanoprobes Assisted NIR-II Fluorescence Imaging for Efficient Angiography and Tumor Therapy.用于高效血管造影和肿瘤治疗的诊疗纳米探针辅助近红外二区荧光成像
ACS Omega. 2025 May 15;10(20):20674-20685. doi: 10.1021/acsomega.5c01553. eCollection 2025 May 27.
2
Threshold size criterion to suspect malignant supraclavicular lymph node < 10 mm in esophageal cancer.怀疑食管癌患者锁骨上淋巴结恶性病变的阈值大小标准为<10毫米。
Insights Imaging. 2025 Mar 5;16(1):50. doi: 10.1186/s13244-025-01929-3.
3
Value of Computed Tomography Scan for Detecting Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma.

本文引用的文献

1
Risk factors for tumor recurrence in patients with pTNM thoracic esophageal squamous cell carcinoma after esophagectomy.胸段食管鳞癌患者术后肿瘤复发的危险因素分析
J Int Med Res. 2020 Dec;48(12):300060520977403. doi: 10.1177/0300060520977403.
2
Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis.评估 cN0 胸段食管癌患者病理淋巴结诊断不一致的转移性淋巴结。
World J Surg Oncol. 2020 May 29;18(1):111. doi: 10.1186/s12957-020-01880-1.
3
Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma.
计算机断层扫描在早期食管鳞状细胞癌淋巴结转移检测中的价值
Ann Surg Oncol. 2025 Mar;32(3):1635-1650. doi: 10.1245/s10434-024-16568-z. Epub 2024 Nov 25.
4
Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB-IVA esophageal squamous cancer.不同手术入路对 IIB-IVA 期食管鳞癌术后放疗患者预后的影响。
World J Surg Oncol. 2022 Aug 30;20(1):271. doi: 10.1186/s12957-022-02739-3.
5
Sex differences in cancer-specific survival for locally advanced esophageal cancer after neoadjuvant chemoradiotherapy: A population-based analysis.新辅助放化疗后局部晚期食管癌癌症特异性生存的性别差异:一项基于人群的分析。
Front Surg. 2022 Jul 29;9:989204. doi: 10.3389/fsurg.2022.989204. eCollection 2022.
6
Prognostic Nomogram for Predicting Long-Term Overall Survival of Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Plus Surgery: A Population-Based Study.预测接受新辅助放化疗加手术的食管癌患者长期总生存的预后列线图:一项基于人群的研究
Front Surg. 2022 May 25;9:927457. doi: 10.3389/fsurg.2022.927457. eCollection 2022.
7
Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy.微创 Ivor Lewis 食管切除术治疗食管癌的长期生存结果。
World J Surg Oncol. 2022 Feb 25;20(1):50. doi: 10.1186/s12957-022-02518-0.
胸段 T3N0M0 食管鳞癌术后辅助化疗。
Ann Surg Oncol. 2020 May;27(5):1488-1495. doi: 10.1245/s10434-019-08112-1. Epub 2020 Jan 23.
4
Current state of esophageal cancer surgery in China: a national database analysis.中国食管癌外科手术的现状:国家数据库分析。
BMC Cancer. 2019 Nov 8;19(1):1064. doi: 10.1186/s12885-019-6191-2.
5
Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes.通过根治性淋巴结清扫术在治疗食管鳞状细胞癌时实现充分的淋巴结清扫:超越所收获淋巴结数量的范畴。
Oncol Lett. 2019 Aug;18(2):1617-1630. doi: 10.3892/ol.2019.10465. Epub 2019 Jun 12.
6
Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma.病理T3N0M0期食管鳞状细胞癌的辅助治疗
J Thorac Dis. 2019 Jun;11(6):2512-2522. doi: 10.21037/jtd.2019.05.70.
7
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.食管和胃食管交界处癌,2019 年第 2 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.
8
Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.微创 Ivor Lewis 食管切除术与左开胸食管切除术治疗食管鳞癌的比较:倾向评分匹配分析。
BMC Cancer. 2019 May 27;19(1):500. doi: 10.1186/s12885-019-5656-7.
9
Clinical implication of the innovations of the 8 edition of the TNM classification for esophageal and esophago-gastric cancer.第8版食管癌和食管胃癌TNM分类创新的临床意义
J Thorac Dis. 2018 Aug;10(Suppl 22):S2671-S2681. doi: 10.21037/jtd.2018.03.182.
10
Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment.经颈纵隔镜辅助淋巴结清扫术联合左开胸食管癌切除术与右开胸食管癌切除术治疗食管癌的疗效比较。
World J Surg Oncol. 2018 Feb 9;16(1):25. doi: 10.1186/s12957-017-1268-3.